Doxepin Related Compound C (25 mg) ((E-3-(dibenzo[b,e]oxepin-11(6H)-ylidene)-N-methylpropan-1-amine hydrochloride) (4504-96-5)

Other Product

• Olopatadine Related Compound B (35 mg) ((Z)-3-{2-(carboxymethyl)dibenzo[b,e]oxepin-11(6H)-ylidene}-N,N-dimethylpropan-1-amine oxide)
• (3E)-3-dibenzo[b,e]oxepin-11(6H)-ylidene-N,N-dimethylpropan-1-amine acetate
• (4E)-4-dibenzo[b,e]oxepin-11(6H)-ylidene-N,N,2-trimethylbutan-2-amine hydrochloride
• (3E)-3-(Dibenzo[b,e]oxepin-11(6H)-ylidene)-N,N-dimethyl-1-propana mine
• 1-Propanamine,3-(dibenz[b,e]oxepin-11(6H)-ylidene)-N-methyl-, hydrochloride (1:1)
• 4,4'-methanediylbis(3-hydroxynaphthalene-2-carboxylic acid) - (3E)-3-dibenzo[b,e]oxepin-11(6H)-ylidene-N,N-dimethylpropan-1-amine (1:2)
• 1-Propanamine,3-dibenzo[b,e]thiepin-11(6H)-ylidene-N,N-dimethyl-, hydrochloride, (E)- (9CI)
• 1-Propanamine,3-(dibenzo[b,e]thiepin-11(6H)-ylidene)-N,N-dimethyl-, hydrochloride (1:1)
• 1-Propanamine,3-dibenzo[b,e]thiepin-11(6H)-ylidene-N,N-dimethyl-, hydrochloride, (Z)- (9CI)
• 1-Propanamine,3-(dibenz[b,e]oxepin-11(6H)-ylidene-1,2,3,4-d4)-N-methyl-, (E)- (9CI)
• 1-Propanamine,3-(dibenz[b,e]oxepin-11(6H)-ylidene)-N,N-dimethyl-, hydrochloride (1:1), (3Z)-
• 1-Propanamine,3-dibenz[b,e]oxepin-11(6H)-ylidene-N-methyl-N-(methyl-d3)-, hydrochloride (9CI)
• 1-Propanamine,3-dibenz[b,e]oxepin-11(6H)-ylidene-, hydrochloride, (Z)- (9CI)
• Tenofovir Disoproxil Related Compound B (10 mg) ((E)-9-(Prop-1-enyl)-9H-purin-6-amine)
• 1-Propanamine,3-dibenz[b,e]oxepin-11(6H)-ylidene-N,N-dimethyl-
• Atomoxetine Related Compound C (10 mg) (N-methyl-3-phenyl-3-(p-tolyloxy)propan-1-amine hydrochloride)
• (3E)-3-(6,7-dihydro-12H-dibenzo[b,e]thiocin-12-ylidene)-N-methylpropan-1-amine
• 1-Propanamine,3-(dibenz[b,e]oxepin-11(6H)-ylidene-1,2,3,4-d4)-N-methyl-, (Z)- (9CI)
• 1-Propanamine,3-dibenz[b,e]oxepin-11(6H)-ylidene-N-methyl-
• (E)-N-(3-Dibenzo(b,e)thiepin-11(6H)-ylidenepropyl)-N-methyl-2-propyn-1-amine hydrochloride